Corneal marking methods reduce astigmatism

Article

Accurate corneal marking before surgery leads to a reduction in astigmatism.

Accurate corneal marking before surgery leads to a reduction in astigmatism.

The randomized, examiner-masked clinical trial, led by Dr N. Popp, Vienna Institute for Research in Ocular Surgery, Vienna, Austria, enrolled 60 patients with astigmatism. Four corneal astigmatic marking methods were tested: marking at the slitlamp with an insulin needle, a pendular marker, a bubble marker and a tonometer marker. A standardized photographic technique was used to document the corneal marks and the rotational deviation and vertical misalignment were assessed.

The pendular-marking device demonstrated the least rotational deviation to the reference medium and there was no statistically significant difference between slitlamp marking and pendular marking.

However, there was a significant difference between the pendular marker and the tonometer marker. The slitlamp-marking device presented with the least vertical misalignment, but there was no statistically significant difference in vertical misalignment between the four corneal markers.

To read the abstract please visit the Journal of Cataract and Refractive Surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.